Special scans track Cancer's reaction to drugs
NCT ID NCT02608216
Summary
This study uses a special type of PET scan to watch how metastatic breast cancer responds to two cancer drugs. Researchers want to see if changes on these scans can predict how well the treatment is working. The study involves 20 patients who are already receiving the drugs through a separate treatment trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.